Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Clinical and Translational Medicine|October 7, 2016
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinomaSven H Loosen, Fabian Benz, Jennifer Niedeggen, et al.
Critical Care Medicine|January 14, 2014
Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patientsFrank Tacke, Christoph Roderburg, Fabian Benz, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisChristoph Roderburg, Gerd-Willem Urban, Kira Bettermann, et al.
Mediators of Inflammation|December 12, 2022
Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract CancerChristoph Roderburg, Simon Labuhn, Jan Bednarsch, et al.
Disease Markers|November 28, 2019
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic CancerSven H Loosen, Mark Luedde, Georg Lurje, et al.
Advanced Drug Delivery Reviews|June 17, 2021
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disordersAlexandros Marios Sofias, Federica De Lorenzi, Quim Peña, et al.
Journal of Digestive Diseases|June 30, 2015
miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosisSanchari Roy, Fabian Benz, David Vargas Cardenas, et al.
Journal of Hepatology|November 28, 2012
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosisChristoph Roderburg, Mark Luedde, David Vargas Cardenas, et al.
Cancers|September 9, 2022
Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract CancerSven H Loosen, Tom F Ulmer, Simon Labuhn, et al.
Pageof 9